# Codexis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/codexis

- Industry: Biotechnology
- Headquarters: Redwood City, US
- Website: www.codexis.com
- Total disclosed funding: $5M
- Latest round: Series D (Nov 13, 2007)
- Investors on record: 6

## About

Founded in 2002 and based in California, US, Codexis, Inc. is a biotechnology company that focuses on developing engineered proteins for use in various industries such as pharmaceuticals, biotherapeutics, food and beverages, and molecular diagnostics. In February 2024, Codexis, Inc. raised USD 40 million in venture debt funding for Innovatus Capital Partners. The company is publicly listed on Nasdaq under the ticker symbol CDXS. As of July 204, Stephen Dilly is the CEO of the company.

Codexis, Inc. offers a range of products and services centered around engineered enzymes for various applications. These include biocatalysts for efficient pharmaceutical manufacturing, IVT enzymes for high-quality mRNA production, and enzymes for next-generation sequencing (NGS) library preparation. Codexis also provides PCR and LAMP enzymes for nucleic acid detection and custom enzyme development services, assisting partners in creating solutions for specific needs. The company’s products are designed to enhance process efficiency, improve yields, and support innovation across pharmaceutical, RNA manufacturing, and life science research industries.

The company plans to use its proceeds from February 2024 funding to accelerate the development and commercialization of its ECO Synthesis™ manufacturing platform for RNAi therapeutics.

## Funding rounds

- Series D, Nov 13, 2007, $5M — Presidio Partners, Malaysian Technology Development, Chevron Technology Ventures, SG Growth Capital, FirstMark Capital, Maxygen

## Investors

- Presidio Partners (https://capitalatlas.ai/funds/presidio-partners) — Series D
- Malaysian Technology Development (https://capitalatlas.ai/funds/malaysian-technology-development) — Series D
- Chevron Technology Ventures (https://capitalatlas.ai/funds/chevron-technology-ventures) — Series D
- SG Growth Capital (https://capitalatlas.ai/funds/sg-growth-capital) — Series D
- FirstMark Capital (https://capitalatlas.ai/funds/firstmark-capital) — Series D
- Maxygen — Series D